Respiratory nursing care with Angong Niuhuang pill for patients with chronic obstructive pulmonary disease following cardiac surgery

Jpn J Nurs Sci. 2021 Jan;18(1):e12344. doi: 10.1111/jjns.12344. Epub 2020 Sep 13.

Abstract

Aim: Angong Niuhuang pill (ANP) is a traditional Chinese medicine (TCM) drug widely used for treating stroke. This study aimed to investigate the effect of ANP on respiratory nursing outcomes in chronic obstructive pulmonary disease (COPD) patients following cardiac surgery.

Methods: A total of 80 COPD patients following cardiac surgery were enrolled and randomized into the control group receiving routine postoperative nursing and ANP group additionally receiving ANP treatment for 3 days (n = 40 for both group). The frequency of back percussion, time of back percussion, amount of expectoration, arterial blood gas levels were compared between groups.

Results: Compared to the control group, the ANP group had a significantly shorter daily mean time of back percussion at day 3 (p = .036) and day 7 (p = .014). The daily mean amount of expectoration was higher at day3 (p = .018) but lower at day 7 (p = .043) in the ANP group than in the control group. In addition, the ANP group had significantly higher hemoglobin saturation (SpO2 ) and partial pressure of oxygen (PaO2 ) but lower partial pressure of carbon dioxide (PaCO2 ) at both day 3 and day 7 than the control group (all p < .05). Furthermore, the time of postoperative aerosol inhalations (p = .041), pulmonary infection rate (p = .025) and postoperative hospital stay (p = .036) were significantly reduced in the ANP group. The ANP group had significantly lower TCM symptom scores at day 3 and day 7 after surgery.

Conclusion: These results suggested that ANP treatment can effectively promote the postoperative recovery and respiratory nursing outcomes in COPD patients following cardiac surgery.

Keywords: Angong Niuhuang pill; cardiac surgery; chronic obstructive pulmonary disease (COPD); respiratory nursing.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cardiac Surgical Procedures*
  • Drugs, Chinese Herbal* / therapeutic use
  • Humans
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Stroke*

Substances

  • Angong Niuhuang Pill
  • Drugs, Chinese Herbal